ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

NCI-Approved Clinical Trials

February 23, 2007

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

Half-Percent NIH, NCI Budget Raise Is Not Enough, Advocates Say

December 19, 2014

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

CSR Draft Report Proposes New Panel To Review Clinical Oncology Research

February 20, 1998